PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Feb-2021 Antivenom Drugs Market is Projected to Grow Massively in Near Future By Top Manufactures: Instituto Bioclon, S.A de C.V, Pfizer Inc., F. Hoffmnn-La Roche Ltd, Merck & Co., Inc., Rare Disease Therapeutics CDN Newswire
02-Feb-2021 Virtual Reality Neuropsychological Therapy Market Set to Register healthy CAGR Forecast to 2027 by Top Prominent Key Players: Vicarious Surgical Inc., Siemens Healthcare Private Limited, Virtalis LTD., CAE HEALTHCARE, General Electric CDN Newswire
02-Feb-2021 Shorter radiotherapy course reduces risk of bladder cancer returning The Institute of Cancer Research, London
02-Feb-2021 CHMP Issues Positive Opinion Recommending Ofatumumab in Relapsing Multiple Sclerosis Genmab A/S
02-Feb-2021 AMARIN RECEIVES POSITIVE CHMP OPINION FOR ICOSAPENT ETHYL FOR CARDIOVASCULAR RISK REDUCTION Amarin Corporation plc
02-Feb-2021 Sputnik V vaccine authorized in Tunisia The Russian Direct Investment Fund
02-Feb-2021 Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration with Metrion Biosciences Sosei Heptares
02-Feb-2021 Janssen Announces CAR-T Therapy Ciltacabtagene Autoleucel (Cilta-cel) Accepted for Accelerated Assessment in Europe for the Treatment of Patients with Heavily Pretreated Multiple Myeloma Janssen
02-Feb-2021 RauCon Guarantees Business Development Event Planning Dependability RauCon
02-Feb-2021 Sputnik V vaccine authorized in Armenia The Russian Direct Investment Fund
02-Feb-2021 Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications Recipharm and Medspray
02-Feb-2021 Prothena Announces Confirmatory Phase 3 AFFIRM-AL Study of Birtamimab in Mayo Stage IV Patients with AL Amyloidosis under SPA Agreement with FDA Prothena
02-Feb-2021 Tiziana Reports Positive Data from the Clinical Study of Nasal Administration with Foralumab, its proprietary fully human anti-CD3 monoclonal antibody, in COVID-19 Patients in Brazil Tiziana
02-Feb-2021 Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD Verona Pharma
02-Feb-2021 Harbour BioMed and ProBioGen Agree on a GlymaxX® License to Fast-Track Cell Line Development Projects Harbour BioMed and ProBioGen
02-Feb-2021 ONTOZRYTM (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults* Arvelle Therapeutics
02-Feb-2021 A vaccine for all mankind: Sputnik V’s efficacy in fighting COVID-19 is validated by internationally peer reviewed data published in The Lancet Russian Direct Investment Fund
02-Feb-2021 Bristol Myers Squibb Announces Positive Topline Results from Second Pivotal Phase 3 Psoriasis Study Showing Superiority of Deucravacitinib Compared to Placebo and Otezla® (apremilast) Bristol Myers Squibb
02-Feb-2021 PUSH DOCTOR PARTNERS WITH WELL PHARMACY TO LAUNCH THE COUNTRY’S FIRST ‘PHARMACY-FIRST’ DIGITAL HEALTH SERVICE PUSH DOCTOR
02-Feb-2021 Novartis receives positive CHMP opinion for Kesimpta® (ofatumumab), a self-administered treatment for adult patients with relapsing multiple sclerosis with active disease Novartis